Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aponte

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
Malaria Journal|November 7, 2025
Accuracy of recording and reporting of malaria rapid diagnostic tests in NigeriaSunday Atobatele, Sidney Sampson, Evelyn Orya, et al.
The Journal of Infectious Diseases|July 3, 2009
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican childrenJahit Sacarlal, Pedro Aide, John J Aponte, et al.
Plos One|August 7, 2018
Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trialSamantha Rada, Jutta Gamper, Raquel González, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
The Journal of Infectious Diseases|August 2, 2025
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected AdultsTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
Frontiers in Immunology|March 22, 2021
Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in MozambiqueSelena Alonso, Marta Vidal, Gemma Ruiz-Olalla, et al.
Lancet (London, England)|October 24, 2007
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialJohn J Aponte, Pedro Aide, Montse Renom, et al.
Plos One|March 14, 2012
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trialCaterina Guinovart, Carlota Dobaño, Quique Bassat, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic SettingTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
Malaria Journal|November 7, 2025
Accuracy of recording and reporting of malaria rapid diagnostic tests in NigeriaSunday Atobatele, Sidney Sampson, Evelyn Orya, et al.
The Journal of Infectious Diseases|July 3, 2009
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican childrenJahit Sacarlal, Pedro Aide, John J Aponte, et al.
Plos One|August 7, 2018
Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trialSamantha Rada, Jutta Gamper, Raquel González, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
The Journal of Infectious Diseases|August 2, 2025
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected AdultsTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
Frontiers in Immunology|March 22, 2021
Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in MozambiqueSelena Alonso, Marta Vidal, Gemma Ruiz-Olalla, et al.
Lancet (London, England)|October 24, 2007
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialJohn J Aponte, Pedro Aide, Montse Renom, et al.
Plos One|March 14, 2012
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trialCaterina Guinovart, Carlota Dobaño, Quique Bassat, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic SettingTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
Pageof 19